The Toronto Concussion Study: Sense of smell is not associated with concussion severity or recovery.


Journal

Brain injury
ISSN: 1362-301X
Titre abrégé: Brain Inj
Pays: England
ID NLM: 8710358

Informations de publication

Date de publication:
12 05 2022
Historique:
pubmed: 17 2 2022
medline: 15 6 2022
entrez: 16 2 2022
Statut: ppublish

Résumé

To examine sense of smell as a biomarker for both severity and duration of post-concussion symptoms. Participants were recruited prospectively from an outpatient concussion clinic. Sense of smell was assessed using the University of Pennsylvania Smell Identification Test (UPSIT) within 7 days, and 4, 8 - or 16-weeks post-injury. UPSIT normative data were used as normal controls. The main outcomes were: symptom severity on the Sport Concussion Assessment Tool 3 (SCAT3) symptom inventory and time to physician-declared recovery. A total of 167 participants (mean age 32.9 [SD, 12.2] years, 59% female [n = 99]) were classified at 1 week post injury as follows: severe hyposmia in 5 (3%), moderate hyposmia in 10 (6%), mild hyposmia in 48 (29%), and normosmia in 104 (62%) individuals. A convenience sample of 81 individuals with concussion were tested at follow-up. Acute impairment of sense of smell following concussion was not associated with symptom severity on the SCAT3 or time to recovery. Sense of smell was stable from baseline to follow-up in this population. This study provides evidence that routine testing of sense of smell in individuals with concussion is not warranted as a biomarker for severity of concussion and concussion recovery.

Identifiants

pubmed: 35171730
doi: 10.1080/02699052.2022.2037713
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

759-767

Auteurs

Evan Foster (E)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.
Translational Research Program, University of Toronto, Toronto, Ontario, Canada.

Mark Bayley (M)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.
Physiatry, University of Toronto, Toronto, Ontario, Canada.

Laura Langer (L)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.

Cristina Saverino (C)

Altum Health, University Health Network, Toronto, Ontario, Canada.

Tharshini Chandra (T)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.

Claire Barnard (C)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.

Paul Comper (P)

KITE, Toronto Rehabilitation Institute - University Health Network, Toronto, Ontario, Canada.
Rehabilitation Sciences Institute, University of Toronto, Toronto, Ontario, Canada.
Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH